Literature DB >> 14741421

Association of drug abuse with inhibition of HIV-1 immune responses: studies with long-term of HIV-1 non-progressors.

Madhavan P N Nair1, S Mahajan, R Hewitt, Z R B Whitney, S A Schwartz.   

Abstract

Recreational drug use has been proposed to affect the course of human immunodeficiency virus (HIV) infections. To investigate the effects of substance abuse on HIV infections, we compared virus-specific cytotoxic T lymphocyte (CTL) responses and the expression of IL-16, TGF-beta1, and CXCR4 in three different cohorts of HIV-infected patients: (1) long-term nonprogressors (LT-NPs) of HIV infection who do not use recreational drugs; (2) nondrugs using normal progressors (NPs), and (3) drugs using NPs. Our results show that LT-NPs manifest increased CTL activity and IL-16 expression and decreased expression of TGF-beta1 and CXCR4 compared to NPs, regardless of recreational drug usage. Furthermore, drugs using NPs showed significantly lower levels of CTL and IL-16 expression and increased TGF-beta1 and CXCR4 expression compared to nondrugs using NPs. Our results suggest that recreational drug use may reduce CTL and IL-16 expression and increase the expression of TGF-beta1 and CXCR4, all of which may facilitate progression of HIV infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14741421     DOI: 10.1016/j.jneuroim.2003.10.038

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

Review 1.  Cannabinoid neuroimmune modulation of SIV disease.

Authors:  Patricia E Molina; Angela Amedee; Nicole J LeCapitaine; Jovanny Zabaleta; Mahesh Mohan; Peter Winsauer; Curtis Vande Stouwe
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-10       Impact factor: 4.147

2.  The impact of non-concordant self-report of substance use in clinical trials research.

Authors:  C Brendan Clark; Cosmas M Zyambo; Ye Li; Karen L Cropsey
Journal:  Addict Behav       Date:  2016-02-17       Impact factor: 3.913

Review 3.  Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model.

Authors:  Patricia E Molina; Angela M Amedee; Peter Winsauer; Steve Nelson; Gregory Bagby; Liz Simon
Journal:  J Neuroimmune Pharmacol       Date:  2015-03-21       Impact factor: 4.147

Review 4.  Molecular targets of opiate drug abuse in neuroAIDS.

Authors:  K F Hauser; N El-Hage; S Buch; J R Berger; W R Tyor; A Nath; A J Bruce-Keller; P E Knapp
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

5.  NeuroAIDS, drug abuse, and inflammation: building collaborative research activities.

Authors:  Joan W Berman; Monica J Carson; Linda Chang; Brian M Cox; Howard S Fox; R Gilberto Gonzalez; Glen R Hanson; Kurt F Hauser; Wen-Zhe Ho; Jau-Shyong Hong; Eugene O Major; William F Maragos; Eliezer Masliah; Justin C McArthur; Diane B Miller; Avindra Nath; James P O'Callaghan; Yuri Persidsky; Christopher Power; Thomas J Rogers; Walter Royal
Journal:  J Neuroimmune Pharmacol       Date:  2006-11-08       Impact factor: 4.147

Review 6.  Impact of Alcohol on HIV Disease Pathogenesis, Comorbidities and Aging: Integrating Preclinical and Clinical Findings.

Authors:  Patricia E Molina; Liz Simon; Angela M Amedee; David A Welsh; Tekeda F Ferguson
Journal:  Alcohol Alcohol       Date:  2018-07-01       Impact factor: 2.826

7.  Drug-related talaromycosis: A case report.

Authors:  Yongsheng Lu; Quan Shi; Jing Yu
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.